Australia Knee Replacement Market Overview, 2031

Knee replacement market of Australia has shown steady performance, supported by rising demand across public and private healthcare systems. Drivers of growth include an aging population, increasing prevalence of osteoarthritis, obesity-related joint degeneration, and advancements in minimally invasive surgical techniques. The purpose and benefits of knee replacement procedures lie in restoring mobility, reducing pain, and improving quality of life for patients suffering from severe joint damage. Historically, knee replacement surgeries in Australia began in the late 20th century with conventional implants, evolving in the 1990s into advanced prosthetics with improved longevity and biocompatibility. The scope of products includes total knee replacement implants, partial knee replacement devices, revision implants, and customized prosthetics. The scope of technology extends to robot-assisted surgery, 3D-printed implants, computer navigation systems, and advanced biomaterials such as titanium alloys and polyethylene liners. Market components involve implant manufacturers, distributors, hospitals, orthopedic surgeons, rehabilitation centers, and government health agencies. Policies emphasize compliance with Therapeutic Goods Administration (TGA) regulations, Medicare reimbursement frameworks, and national surgical safety standards. Challenges include high surgical costs, long waiting times in public hospitals, and limited access in rural regions. Cultural trends highlight Australia’s strong focus on active aging, sports injury recovery, and patient-centric care, with customer behaviour showing preference for minimally invasive procedures, faster recovery times, and advanced implant technologies. Connection to the parent orthopedic devices market is strong, as knee replacement forms a critical sub-segment driving innovation in joint reconstruction and musculoskeletal healthcare. The growing adoption of day-surgery models for knee replacement is reshaping patient expectations around recovery time. Customers are increasingly requesting digital rehabilitation apps linked to surgical outcomes, reflecting a shift toward tech-enabled post-care.

According to the research report, "Australia Knee Replacement Overview, 2031," published by Bonafide Research, the Australia Knee Replacement is anticipated to grow at more than 5.5% CAGR from 2026 to 2031.The competitive landscape of Australia’s knee replacement market blends global orthopedic giants with local distributors and healthcare providers. International firms such as Zimmer Biomet, Stryker, Johnson & Johnson (DePuy Synthes), and Smith & Nephew dominate, while local players like Exactech Australia, Orthotech, and Global Orthopaedic Technology (GOT) provide regionally tailored solutions. Their products and services include total and partial knee implants, revision systems, surgical navigation tools, and patient-specific prosthetics. Local firms’ USPs lie in affordability, customization, and strong partnerships with Australian hospitals. Business models vary global firms emphasize large-scale hospital contracts and proprietary implant technologies, while local companies rely on distribution networks, surgeon-focused training programs, and niche customization services. Price ranges differ significantly, standard knee replacement implants may cost AUD 5,000-8,000, while advanced robotic-assisted or customized implants can exceed AUD 12,000-15,000 depending on complexity. Market trends include adoption of robotic-assisted knee replacement, expansion of outpatient surgical centers, and integration of digital rehabilitation platforms. Opportunities are strong in regional healthcare expansion, sports medicine, and personalized implants, where demand for advanced solutions is rising. Latest news highlights Zimmer Biomet expanding robotic surgery programs in Australian hospitals, Stryker launching new cementless knee implants, and Global Orthopaedic Technology partnering with local universities on 3D-printed prosthetic research. The market is also witnessing collaborations between healthcare providers and technology firms on AI-driven surgical planning and patient recovery monitoring, reinforcing Australia’s role in advancing orthopedic innovation. Local firms are expanding into value-based care partnerships with hospitals, aligning pricing with patient outcomes. Several companies are piloting bioceramic-coated implants for enhanced longevity, positioning Australia as a hub for advanced orthopedic innovation.

The Australia knee replacement market is segmented into total knee replacement, partial knee replacement, revision knee replacement, unicompartmental knee replacement, patellofemoral replacement, and complex primary procedures, each addressing specific patient needs and clinical scenarios. These procedure types reflect the diverse clinical pathways shaping Australia’s knee replacement market, balancing mainstream demand with specialized interventions. Total knee replacement remains the most common procedure, performed for patients with advanced osteoarthritis or severe joint damage. In Australia, it is widely adopted across public and private hospitals, offering long‑term pain relief and improved mobility, supported by advancements in minimally invasive techniques and prosthetic materials. Partial knee replacement is suited for patients with localized damage, preserving healthy tissue and enabling faster recovery. In Australia, demand is rising among younger, active patients seeking less invasive options with shorter rehabilitation times. Revision knee replacement is performed when previous implants fail due to wear, infection, or loosening. In Australia, this segment is growing as the aging population with earlier implants requires corrective procedures, often involving more complex surgical planning. Unicompartmental knee replacement targets damage confined to a single compartment of the knee, offering a conservative alternative to total replacement. In Australia, it is increasingly favoured for patients with medial compartment arthritis, providing natural joint movement and reduced hospital stays. Patellofemoral replacement addresses damage limited to the kneecap and femoral groove. In Australia, this procedure is less common but valuable for patients with isolated patellofemoral arthritis, offering pain relief while preserving other joint structures. Complex primary procedures involve cases with severe deformities, bone loss, or comorbidities requiring advanced surgical expertise. In Australia, tertiary hospitals and specialized orthopedic centers perform these procedures, emphasizing customized implants and multidisciplinary care.

The Australia knee replacement market is segmented into hospital and surgical centers, ambulatory surgery centers, specialty orthopedic clinics, academic medical centers, outpatient surgical facilities, and multi‑specialty healthcare systems, each reflecting distinct care delivery models. These end‑user segments highlight the diverse ecosystem supporting knee replacement procedures across Australia’s healthcare landscape. Hospitals and surgical centers dominate the market, performing the majority of knee replacement procedures due to their advanced infrastructure, access to skilled surgeons, and ability to manage complex cases. In Australia, public and private hospitals remain the primary hubs for total and revision knee replacements, supported by government funding and insurance coverage. Ambulatory surgery centers (ASCs) are gaining traction as minimally invasive techniques and faster recovery protocols enable same‑day procedures. In Australia, ASCs appeal to patients seeking cost‑effective, efficient care with reduced hospital stays, particularly for partial and unicompartmental replacements. Specialty orthopedic clinics focus exclusively on musculoskeletal care, offering personalized treatment plans and advanced rehabilitation programs. In Australia, these clinics are preferred for their expertise, patient‑centric approach, and emphasis on innovative surgical techniques. Academic medical centers play a dual role, conducting knee replacement surgeries while driving research, training, and clinical trials. In Australia, they contribute to advancements in prosthetic design, surgical methods, and post‑operative care standards. Outpatient surgical facilities cater to patients requiring less invasive procedures, supported by enhanced anesthesia and recovery protocols. In Australia, these facilities are expanding in urban areas, offering convenience and affordability for selected patient groups. Multi‑specialty healthcare systems integrate orthopedic services within broader networks, providing comprehensive care that includes diagnostics, surgery, and rehabilitation. In Australia, these systems ensure continuity of care, leveraging multidisciplinary expertise to improve patient outcomes.

The Australia knee replacement market is segmented into implants, surgical instruments, navigation systems, robotic systems, patient‑specific instrumentation, and surgical accessories, each representing critical components of modern orthopedic care. These product types illustrate how implants anchor demand, instruments and accessories sustain procedural efficiency, and advanced systems like robotics, navigation, and PSI drive innovation in Australia’s knee replacement market. Implants form the largest segment, encompassing prosthetic devices designed to replace damaged knee joints. In Australia, demand for implants is driven by rising osteoarthritis prevalence and an aging population, with innovations in biocompatible materials and minimally invasive designs enhancing patient outcomes. Surgical instruments include precision tools required for joint replacement procedures, such as saws, drills, and fixation devices. In Australia, hospitals and surgical centers prioritize high‑quality instruments to ensure accuracy, reduce complications, and support faster recovery. Navigation systems provide digital guidance during surgery, improving alignment and implant positioning. In Australia, adoption is increasing in advanced orthopedic centers, where surgeons leverage computer‑assisted technologies to enhance precision and reduce revision rates. Robotic systems represent a rapidly growing segment, offering automation and real‑time analytics for knee replacement procedures. In Australia, robotic platforms are gaining traction in tertiary hospitals and private clinics, valued for their ability to personalize surgeries and improve long‑term implant performance. Patient‑specific instrumentation (PSI) involves customized surgical guides based on individual anatomy, created using imaging and 3D printing. In Australia, PSI adoption is expanding among patients seeking tailored solutions that minimize invasiveness and optimize fit. Surgical accessories include consumables such as drapes, fixation pins, and sterilization products, essential for maintaining safety and efficiency in operating rooms. In Australia, accessories support procedural consistency and infection control, forming a vital part of the overall supply chain.



Considered in this report
•Historic Year: 2020
•Base Year: 2025
•Estimated Year: 2026
•Forecast Year: 2031

Aspects covered in this report
• Australia Knee Replacement Market with its value and forecast along with its segments
• Various drivers and challenges
• Ongoing trends and developments
• Top profiled companies
• Strategic recommendation

By Procedure Type
• Total Knee Replacement
• Partial Knee Replacement
• Revision Knee Replacement
• Unicompartmental Knee Replacement
• Patellofemoral Replacement
• Complex Primary Procedures

By End-User
• Hospital and Surgical Centers
• Ambulatory Surgery Centers
• Specialty Orthopedic Clinics
• Academic Medical Centers
• Outpatient Surgical Facilities
• Multi-specialty Healthcare Systems

By Product Type
• Implants
• Surgical Instruments
• Navigation Systems
• Robotic Systems
• Patient-Specific Instrumentation
• Surgical Accessories